AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 291: H781-H786, 2006. First published March 24, 2006; doi:10.1152/ajpheart.00045.2006
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/2/H781    most recent
00045.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Santhanam, A. V. R.
Right arrow Articles by Katusic, Z. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Santhanam, A. V. R.
Right arrow Articles by Katusic, Z. S.

In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries

Anantha Vijay R. Santhanam,1,2 Leslie A. Smith,1,2 Karl A. Nath,3 and Zvonimir S. Katusic1,2

1Departments of Anesthesiology, and 2Molecular Pharmacology and Experimental Therapeutics, and 3Division of Nephrology and Hypertension, Mayo Clinic College of Medicine, Rochester, Minnesota

Submitted 9 January 2006 ; accepted in final form 4 March 2006

The discovery of tissue protective effects of erythropoietin has stimulated significant interest in erythropoietin (Epo) as a novel therapeutic approach to vascular protection. The present study was designed to determine the cerebral vascular effects of recombinant Epo in vivo. Recombinant adenoviral vectors (109 plaque-forming units/animal) encoding genes for human erythropoietin (AdEpo) and beta-galactosidase (AdLacZ) were injected into the cisterna magna of rabbits. After 48 h, basilar arteries were harvested for analysis of vasomotor function, Western blotting, and measurement of cGMP levels. Gene transfer of AdEpo increased the expressions of recombinant Epo and its receptor in the basilar arteries. Arteries exposed to recombinant Epo demonstrated attenuation of contractile responses to histamine (10–9 to 10–5 mol/l) (P < 0.05, n = 5). Endothelium-dependent relaxations to acetylcholine (10–9 to 10–5 mol/l) were significantly augmented (P < 0.05, n = 5), whereas endothelium-independent relaxations to a nitric oxide (NO) donor 2-(N,N-diethylamino)diazenolate-2-oxide sodium salt remained unchanged in AdEpo-transduced basilar arteries. Transduction with AdEpo increased the protein expression of endothelial NO synthase (eNOS) and phosphorylated the S1177 form of the enzyme. Basal levels of cGMP were significantly elevated in arteries transduced with AdEpo consistent with increased NO production. Our studies suggest that in cerebral circulation, Epo enhances endothelium-dependent vasodilatation mediated by NO. This effect could play an important role in the vascular protective effect of Epo.

recombinant adenoviral vectors; vasodilatation; gene transfer; rabbit



Address for reprint requests and other correspondence: Z. S. Katusic, Dept. of Anesthesiology, Mayo Clinic College of Medicine, 200 First St. SW, Rochester, MN 55905 (e-mail: katusic.zvonimir{at}mayo.edu)




This article has been cited by other articles:


Home page
StrokeHome page
A. V. R. Santhanam, L. A. Smith, and Z. S. Katusic
Brain-Derived Neurotrophic Factor Stimulates Production of Prostacyclin in Cerebral Arteries * Supplemental Data
Stroke, February 1, 2010; 41(2): 350 - 356.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. V. R. Santhanam, L. A. Smith, T. He, K. A. Nath, and Z. S. Katusic
Endothelial Progenitor Cells Stimulate Cerebrovascular Production of Prostacyclin By Paracrine Activation of Cyclooxygenase-2
Circ. Res., May 11, 2007; 100(9): 1379 - 1388.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.